5 Biotech Stocks With 105% to 386% Upside, According to Wall Street
Since the Great Recession ended more than 12 years ago, innovative, high-growth companies have ruled the roost on Wall Street. Historically low lending rates and an abundance of cheap capital have allowed fast-paced companies to borrow in order to hire, acquire, and innovate.
But even after a monster rally in equities, Wall Street still sees significant upside in a handful of companies. In particular, biotech stocks have the attention of select analysts and investment banks.
Based on the high-water price target issued by analysts or investment banks, the following five biotech offer upside ranging from 105% to as much as 386% over the next 12 months.
Source Fool.com
